A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Apr, 22 2026
Apr, 6 2026
Dec, 5 2025
Dec, 3 2025
Nov, 18 2025